BrightSpring Health Services (NASDAQ:BTSG) Sets New 52-Week High on Analyst Upgrade

Shares of BrightSpring Health Services, Inc. (NASDAQ:BTSG) hit a new 52-week high during mid-day trading on Friday after Mizuho raised their price target on the stock from $38.00 to $42.00. Mizuho currently has an outperform rating on the stock. BrightSpring Health Services traded as high as $37.41 and last traded at $37.5410, with a volume of 176289 shares trading hands. The stock had previously closed at $36.64.

BTSG has been the topic of several other research reports. William Blair assumed coverage on BrightSpring Health Services in a research report on Monday, December 8th. They issued an “outperform” rating on the stock. Weiss Ratings reiterated a “hold (c)” rating on shares of BrightSpring Health Services in a research note on Monday. Jefferies Financial Group set a $36.00 price target on shares of BrightSpring Health Services and gave the stock a “buy” rating in a report on Tuesday, October 21st. Wall Street Zen cut shares of BrightSpring Health Services from a “strong-buy” rating to a “buy” rating in a report on Saturday, November 15th. Finally, BMO Capital Markets initiated coverage on shares of BrightSpring Health Services in a research report on Thursday, November 13th. They issued an “outperform” rating and a $40.00 price objective for the company. Two investment analysts have rated the stock with a Strong Buy rating, fourteen have given a Buy rating and one has assigned a Hold rating to the company. According to data from MarketBeat.com, BrightSpring Health Services currently has a consensus rating of “Buy” and an average price target of $39.08.

Insiders Place Their Bets

In other BrightSpring Health Services news, insider Lisa A. Nalley sold 20,000 shares of the stock in a transaction on Wednesday, October 22nd. The shares were sold at an average price of $28.78, for a total transaction of $575,600.00. Following the transaction, the insider directly owned 131,150 shares of the company’s stock, valued at $3,774,497. This trade represents a 13.23% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, insider Jon B. Rousseau sold 235,000 shares of the business’s stock in a transaction dated Wednesday, October 22nd. The stock was sold at an average price of $28.78, for a total transaction of $6,763,300.00. Following the sale, the insider directly owned 1,131,930 shares of the company’s stock, valued at $32,576,945.40. This represents a 17.19% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Corporate insiders own 3.40% of the company’s stock.

Hedge Funds Weigh In On BrightSpring Health Services

A number of hedge funds have recently made changes to their positions in BTSG. CIBC Bancorp USA Inc. acquired a new stake in shares of BrightSpring Health Services in the third quarter worth approximately $296,000. Oberweis Asset Management Inc. raised its stake in BrightSpring Health Services by 17.0% in the 3rd quarter. Oberweis Asset Management Inc. now owns 908,000 shares of the company’s stock valued at $26,840,000 after purchasing an additional 132,200 shares during the last quarter. NewEdge Advisors LLC lifted its holdings in BrightSpring Health Services by 7.2% in the 3rd quarter. NewEdge Advisors LLC now owns 39,768 shares of the company’s stock valued at $1,176,000 after purchasing an additional 2,674 shares in the last quarter. Alyeska Investment Group L.P. boosted its stake in BrightSpring Health Services by 19.0% during the 3rd quarter. Alyeska Investment Group L.P. now owns 1,984,365 shares of the company’s stock worth $58,658,000 after purchasing an additional 316,965 shares during the last quarter. Finally, Verition Fund Management LLC boosted its stake in BrightSpring Health Services by 19.4% during the 3rd quarter. Verition Fund Management LLC now owns 183,361 shares of the company’s stock worth $5,420,000 after purchasing an additional 29,795 shares during the last quarter.

BrightSpring Health Services Price Performance

The stock’s fifty day moving average price is $33.59 and its 200-day moving average price is $27.03. The company has a debt-to-equity ratio of 1.36, a current ratio of 1.79 and a quick ratio of 1.38. The firm has a market cap of $6.77 billion, a PE ratio of 61.38, a price-to-earnings-growth ratio of 0.63 and a beta of 2.36.

BrightSpring Health Services (NASDAQ:BTSG) last posted its quarterly earnings results on Monday, October 20th. The company reported $0.30 earnings per share for the quarter, topping analysts’ consensus estimates of $0.27 by $0.03. The firm had revenue of $3.33 billion for the quarter, compared to analyst estimates of $3.16 billion. BrightSpring Health Services had a net margin of 1.04% and a return on equity of 11.61%. BrightSpring Health Services has set its Q3 2025 guidance at 0.300-0.300 EPS. As a group, equities analysts expect that BrightSpring Health Services, Inc. will post 0.59 EPS for the current fiscal year.

About BrightSpring Health Services

BrightSpring Health Services, Inc operates a home and community-based healthcare services platform in the United States. The company's platform focuses on delivering pharmacy and provider services, including clinical and supportive care in home and community settings to Medicare, Medicaid, and insured populations.